PREVENTING ADVERSE PATIENT RESPONSES TO CANCER CHEMOTHERAPEUTICS

$597,737FY2018Defense Health AgencyDOD

Albert Einstein College Of Medicine, Bronx NY

Investigators

View source on USAspending →